• Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications

Jour : 7 janvier 2026

PredictCan Extends Its Cell Educating Technology™ to Pancreatic Cancer

A new study published in Translational Oncology, in collaboration with clinicians from Montpellier University Hospital, demonstrates the application of PredictCan’s patient-educated models to pancreatic cancer and their ability to reflect individual clinical treatment responses.

PredictCan_Logo_01
  • Privacy Policy
  • Legal Notice
  • Privacy Policy
  • Legal Notice

Follow us

Linkedin Twitter

© 2026 - predictcan | Tous Droits Réservés

By JCD Groupe

  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.